Amgen

Results: 561



#Item
431

Supplemental Appendix A: Conflict of interest (COI) Specific relationships with companies, and respective pharmaceuticals in use representing COI, were: URL Pharma (Colchicine); Takeda (Febuxostat); Amgen / Biovitrum /

Add to Reading List

Source URL: www.rheumatology.org

    432North Carolina Department of Revenue Technology Development Credits Taken Article 3F Processed during Calendar Year 2013 Taxpayer

    North Carolina Department of Revenue Technology Development Credits Taken Article 3F Processed during Calendar Year 2013 Taxpayer

    Add to Reading List

    Source URL: dornc.com

    Language: English - Date: 2014-04-16 09:01:50
    433Kidney Transplant Advisory Committee Members List CHAIR Dr. Edward Cole Amgen Professor of Nephrology and Director Division of Nephrology

    Kidney Transplant Advisory Committee Members List CHAIR Dr. Edward Cole Amgen Professor of Nephrology and Director Division of Nephrology

    Add to Reading List

    Source URL: www.organsandtissues.ca

    Language: English - Date: 2014-07-11 09:48:38
    434Amgen Scholars Program 2012 Annual Report Highlights An Undergraduate Summer Research Program in Science and Biotechnology Through an eight-year, $34 million commitment from the Amgen Foundation, the Amgen Scholars Progr

    Amgen Scholars Program 2012 Annual Report Highlights An Undergraduate Summer Research Program in Science and Biotechnology Through an eight-year, $34 million commitment from the Amgen Foundation, the Amgen Scholars Progr

    Add to Reading List

    Source URL: www.hlc.org

    Language: English - Date: 2014-06-10 12:05:04
    435Scholars Flyer US SideA DEC2013

    Scholars Flyer US SideA DEC2013

    Add to Reading List

    Source URL: www.hlc.org

    Language: English - Date: 2014-06-10 12:05:03
    436Amgen and the Amgen Foundation advance science education by funding innovative programs at every level, from the local elementary school to the

    Amgen and the Amgen Foundation advance science education by funding innovative programs at every level, from the local elementary school to the

    Add to Reading List

    Source URL: www.hlc.org

    Language: English - Date: 2014-06-10 12:05:07
    437Microsoft PowerPoint - Amgen Presentation.pptx

    Microsoft PowerPoint - Amgen Presentation.pptx

    Add to Reading List

    Source URL: www.hlc.org

    Language: English - Date: 2014-06-10 12:04:46
    438HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PROLIA safely and effectively. See full prescribing information for PROLIA. Prolia® (denosumab) Injection, for subc

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PROLIA safely and effectively. See full prescribing information for PROLIA. Prolia® (denosumab) Injection, for subc

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2013-07-05 15:54:00
    439Microsoft PowerPoint - pp3 Amgen_Research[removed]2013_Final.ppt [Compatibility Mode]

    Microsoft PowerPoint - pp3 Amgen_Research[removed]2013_Final.ppt [Compatibility Mode]

    Add to Reading List

    Source URL: www.nasa.gov

    Language: English - Date: 2013-12-05 11:00:14
    440HIGHLIGHTS OF PRESCRIBING INFORMATION These hig hlights do not include all the informatio n nee ded to use XGEVA® safely and effectively. See full prescribing information for XGEVA. Xgeva (denosumab) injection, for subc

    HIGHLIGHTS OF PRESCRIBING INFORMATION These hig hlights do not include all the informatio n nee ded to use XGEVA® safely and effectively. See full prescribing information for XGEVA. Xgeva (denosumab) injection, for subc

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2014-06-06 13:13:18